Febrile is joined by Drs. Brian Bramson, James Lewis, Christian Hendrix, and Erica Kaufman West who discuss an all-too-common scenario and explore how single-payer health care systems may impact ID practice. Learn more about the Single-Payer Interest Group at the bottom of this IDSA page! The Single-Payer Interest Group aims to bring members together to (1) learn about single-payer health care systems (and how it may impact the practice of Infectious Diseases); and (2) advocate for a national single-payer healthcare system in the United States. Join the Single-Payer Interest Group You can also find Physicians for a National Health Program (PNHP) here Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com Febrile is produced with support from the Infectious Diseases Society of America (IDSA)
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
Sara Dong : Hi, everyone. Welcome to Febrile, a cultured podcast about all things infectious disease. We use consult questions to dive into ID clinical reasoning, diagnostics, and antimicrobial management. I'm Sara Dong, your host. We have several guests joining us today to help talk a little bit about the idea of single-payer healthcare in the US. I'll first introduce Dr. Brian Bramson. Brian is a Professor of Medicine at UNC Chapel Hill, where he works as an ID clinician and educator of students, residents, and fellows. Prior to joining the UNC faculty, he worked as clinical director of
community health centers in Central North Carolina, and has lived and worked in Tanzania, Laos, and Malawi. He is a member of the National Board of Directors for Physicians for a National Health Program Brian Bramson: Hi, I'm Brian. I'm excited to be here Sara Dong : Dr. James Lewis is next. James is a public health physician trained in infectious diseases, preventative medicine, and internal medicine He trained in internal medicine at Washington University in St. Louis, followed by training in ID and preventative medicine at UNC Chapel Hill. He also completed his MPH in epidemiology at UNC Gillings
School of Global Public Health. He has now worked in public health for the last ten years at local and state levels in North Carolina and Washington. James Lewis: Hi, I'm James. Thanks for having me Sara Dong : Next we have Dr. Christian Hendrix. Christian aspires to be a revolutionary and a clinician educator within ID and critical care medicine in order to fight health inequity. She has completed the medical education track and ID critical care track through her ID fellowship at WashU, and she now remains at WashU during her transition to critical care fellowship Christian Hendrix: Hey, everybody.
My name's Christian Hendrix. It's great to see you all Sara Dong : And last but not least, we have Dr. Erica Kaufman West. Erica is an infectious disease physician focusing on wounds, HIV, and viral hepatitis. She completed her ID fellowship at the Cedars Sinai-UCLA combined program. She currently is working clinically in Indiana and is the medical director of the infectious disease section of a health system there in Indiana Erica Kaufman West: Hi, I'm Erica. Glad to be here Sara Dong: Before we get started, as everyone's favorite cultured podcast, I always ask our guests to share a little piece of culture,
really just something non-medical, non-work-related that makes you happy. Maybe I'll go backwards. Christian, what about you? Christian Hendrix: Thanks, Sara. So, um, my culture podcast tidbit today is probably gonna be when studying for step one exams, my sister bought me a Groupon for exercise classes that I used for cross-training. So I've been addicted ever since. I really enjoy prioritizing health and doing local competitions with my gym family and fiancé at LAB Gym in St. Louis James Lewis: I can go. This is James and I actually interestingly was also really into
cross-training and did that actively for seven years, and I started in St. Louis where Christian's now in training where I did, uh, did training as well. And then, uh, the big thing I do now is, um, I've gotten into Peloton since the pandemic and really like that. But my big hobby is I collect vinyl records and like doing a lot of things, messing around with those. Brian Bramson: Yeah, um, this is Brian. I used to have a lot more diverse hobbies and interests, but career and other obligations shrank them. My big one is I got interested in brazilian jujitsu way back in
2012 and got completely addicted. Do that several times a week, and actually just got my black belt about three months ago Sara Dong: Wow. Very nice. Brian Bramson: Thank you Erica Kaufman West: For me, I, um, we are maybe the m- the most active, uh, ID group here because we're-- mine is also an activity. So I started doing online yoga during the pandemic and really loved it, so I became a certified yoga instructor, and I am now pursuing my 300-hour training certificate,
which hopefully I'll get, uh, by the end of this year or maybe early next year Sara Dong: Very nice. Well, that's good, you guys. It'll just inspire people to be active after they listen. All right. Okay, so today our case is a 51-year-old female. She has type 2 diabetes, and she has lost her employer-provided insurance. This happened when she left her full-time job to move in with and to care for her ailing parents. She continues to work some weekend shifts in a warehouse without benefits,
and these earnings are high enough to disqualify her for Medicaid eligibility. After losing her health insurance, she stopped seeing her primary care physician or taking her medications. Subsequently, she develops an ulcer near the base of her right great toe that becomes swollen and is draining purulent fluid. She presents to the local emergency department, where X-rays show no evidence of osteomyelitis. She's given a seven-day course of amoxicillin-clavulanate, which she can afford through Walmart. Following this treatment, she gets a little bit better, has some transient
improvement, but unfortunately, the erythema and purulence has returned and is worsening, so she goes back to the emergency room. The hospital social worker helps her get, at this time, still subsidized, ACA coverage with a high deductible plan After this, she is seen in podiatry clinic where her persistent wound is debrided. At this visit, there is a clinical concern for underlying osteomyelitis. So cultures from the wound debridement show mixed gram-positive and gram-negative bacteria with a negative molecular screen for MRSA.
The patient is placed on amoxicillin-clavulanate as well as ciprofloxacin, which again are available at Walmart at low prices. And so she has that for a ten-day course and is referred over to the infectious disease clinic. Fortunately, the patient does get scheduled quickly. She's able to afford the copay for the visit, and the ID physician examines the wound, is also quite worried about osteomyelitis, so they order an MRI, and the insurer requires a time-consuming prior authorization. But eventually, that MRI is approved, and the patient's insurance
has a high annual deductible. This has not been met, and the out-of-pocket costs are prohibitive. So after of this information and these delays, the less preferred CT scan of the foot is ordered instead. The CT report comes back suggesting underlying osteomyelitis of the first and second metatarsals, and she is ultimately taken to the OR with podiatry for a transmetatarsal amputation. Surgical bone margins show osteomyelitis on pathology, and the clean proximal bone
culture shows fluoroquinolone-resistant Pseudomonas aeruginosa. Her treatment plan determined by the ID team is for three weeks of piperacillin-tazobactam IV under the clinic's OPAT supervision. She is able to complete this antibiotic course, but during her course of care, the hospital system and insurer had reached an impasse. The facility where she is seen was labeled as out of network. So during these negotiations, the ninety-day No Surprises Act extension
expires, and the patient cannot afford the cost of uncovered follow-up appointments with either ID or podiatry. Eventually the contract dispute is settled. By the time she arrives at the podiatry and ID clinics for a delayed follow-up, her surgical site shows wound dehiscence and purulence has returned. ID orders an MRI, her deductible was now met, which showed osteomyelitis more proximal to the original margins, and the patient requires a below-the-knee amputation. She is worried about her future employment prospects and her
ability to take care of her parents. So not a totally unfamiliar story and a patient facing so many structural financial barriers and system failure points here just to get help for what I think all of us would agree should be a kinda common run-of-the-mill infection. So what are your thoughts about this? You know, approaching care for patients with barriers due to insurance status. Christian, maybe I'll start with you Christian Hendrix: Sure. Thanks, Sara. So in this patient, we see a system that's clearly failed her.
To summarize, our patient faced barriers to diagnosis, primary care, diagnostics, and treatment. I wish this represented a unique scenario, but I think many physicians agree, and ID physicians agree, that we are faced with this daily. And regarding the approach to our patients, first let's talk about the delay in access to care It's disappointing. Something as simple as ensuring that everyone either meets CDC guidelines for
HIV and Hep C lifetime screening, um, can be daunting when you're implementing an individualized approach to connect patients to care and retain them in care, let alone incorporating principles of health equity to more nuanced patients like we have in this case. And while a lot of work has been done to address barriers to care, we still see delay in access to care. Institutions and government agencies have studied this, especially in patients with poor health outcomes, and we know what the issue is.
For instance, the Healthy People 2020 National Report lists access to care as an initiative because we know that without access to care, our patients with infections, whether it's sexually transmitted infections, HIV, or diabetic foot infections, have worse outcomes. This was reported also in the Institute of Medicine Care Without Coverage report. In the ICU setting with infections as the etiology for septic shock, we can see patients die at higher rates due to insurance impact on their access to care.
And since 1902 the mortality among Negroes in the city of the South, we've researched why some patients literally die, we know we need better healthcare access for our patients. And we also know the impact of medical mistrust and social vulnerability, but it's not a new finding that patients need access to healthcare. I just want to speak a little bit as a fellow physician 'cause I'm often thankful for colleagues who are truly going above and beyond with exemplary efforts and innovation to navigate these types of scenarios for our patients.
But unfortunately, our system proves over and over again that it's still not enough, and we ultimately fail our patients just like this one. And being a part of the system every day leads to moral injury, and we'll talk about that a little bit later, but in addition to this first point, as far as our approach to patients, first we have access to care that's harming patients. And we note that not only is the way we currently finance healthcare harmful in this way in creating barriers to access, but when patients are finally engaged
with care, we face barriers in treatment options, even through medication choices. So for instance, the type of medication that I might want for my patient is going to be different due to cost, and if the insurance company approves my request, that should not be normalized, as other countries such as Cuba or Canada have implemented systems that prove that healthcare access can be universal and doesn't have to be corporatized. And even within our country, the Black Panthers in the US implemented
accessible healthcare, so we know that it's possible, and we don't have to accept that the healthcare system will remain the way it is today. I mean, sitting on the phone for hours pleading for what is ethical truly creates within me a visceral reaction. Like, I'm pleading for medications that are the best option for my patients. And I have patients whose insurance company tells HIV medication they're going to allow, which antifungal treatment they're going to pay for, no matter if it's more expensive or not. Or I had an insurance company tell me that they will only accept
an IV medication for treatment when oral options were available. I mean, fighting prior auths right now has become very ridiculous. I know I've decided I'm not going to accept healthcare the way it is today in the US. I'm gonna fight against it, join anyone in solidarity who's also fighting against it. Many times we can't confirm documentation that an infectious diseases physician has even reviewed these cases, and when we work in multidisciplinary teams with an attending, myself, pharmacy, nurses, and the patient for a medication
approval that's repeatedly denied over months, I'm not gonna accept it. I'm gonna work with others who also won't accept that. And to clarify, losing hours on the phone and communication would not be as disheartening if I knew that the system wouldn't remain the way that it is today. But I do ultimately believe that we'll win in providing equitable care for patients because, like I said, we know what the issue is with our current healthcare system that benefits profit over patients.
So, in this patient and in others, we have a system that, for the first point, is delaying access to care, but also we want to highlight barriers to medications. On top of this, we're battling prior auths, so we can confirm a diagnosis when coordinating, for instance, imaging. And yet, over decades, we have evidence that shows not having access to care is associated with these worse healthcare outcomes. In addition to mortality outcomes, we know that specifically in our patient
and related patient populations, we have even more comorbidities to consider that affects her, like amputation rates. Research studies by vascular surgeons and cardiologists show, and I quote, "Poorer patients and those living in poorer regions of the country have less access to quality healthcare and have the highest amputation rates." And this is in reference to diabetic-associated infections, specifically in patients with peripheral vascular disease.
And James, I know that working in public health, I assume you might have similar evidence to share or similar experiences? James Lewis: Yeah. Thanks, Christian. I just wanna say a really inspiring response. Looking forward to seeing you get out of training and get out there and, uh, and take this on. So thanks for, thanks for your position. Uh, you mentioned a couple publications on this topic, and I thought I would just, at the risk of being a little boring, would throw in a couple more statistics that kind of further illustrate the problem. In the paper, the relationship of health insurance and mortality,
is lack of insurance deadly? Pro-probably don't even need to say the statistic. That's a pretty leading, uh, leading title. Um, uh, but in there, Woolhandler and Himmelstein, uh, all the way back in twenty seventeen, and really we're updating a conclusion from back in 2002 from the Institute of Medicine, showed that the odds of dying among insured relative to uninsured ranged from 0.71 to zero point nine seven, uh, which you can, you know, take to mean essentially uninsurance is associated with excess mortality. Then, uh, in a more recent paper from 2022 called Health Insurance Status and
Cancer Stage at Diagnosis and Survival in the US, again, a pretty leading title, Zhao and, uh, and colleagues showed uninsured and Medicaid-insured patients were significantly more likely to present with higher stage cancer, so stage three and four, and had worse stage-specific survival for twelve of the seventeen stageable cancers. And then it's been, uh, shown in multiple additional papers as well. You know, you can dig into it, uh, pretty easily. And Christian mentioned it, this isn't just diabetic ulcers, HIV patients, or even hep C screening, and all of the other, uh, instances where,
you know, that Christian mentioned. It's cancer, it's diabetes, it's, really kind of every aspect of healthcare. And specifically in my experience working in public health for the last ten years, most of my clinical work recently has been providing care to those who have TB. It's really incredible some of the diagnoses we see that are, it, it just so delayed. So for instance, I had a patient recently with Potts disease who had been presenting with back pain multiple times to the ER over the course of about eighteen months. Had imaging with the history of this person being from, uh, Western
Africa, pretty clearly was Potts disease, but there wasn't, you know, these so-called emergent or alarm symptoms that would, uh, kind of make the an inpatient intervention, uh, happened, and so they kept being discharged from the ER and referred for outpatient workup with neurosurgery. Well, as you can imagine, this person does not have insurance, and so eventually it got to the point where there were, you know, alarm symptoms, and they ended up getting admitted to the hospital and having to have a pretty intense spinal surgery to, to stabilize the spine and, and wash out the infection.
Uh, and their disease course was obviously and comorbidities were much worse than would have, uh, been if that had been addressed, you know, the first or even the second time that, that they had showed up in the ER with a diagnosis that was clear really from the beginning. And then we've had about two patients just in the last year and a half present with very advanced TB to the ER, resulting in death and even in one instance, a transmission to a healthcare worker, uh, uh, during the care trying to save that patient's life. So, this is a real problem, and it, it definitely is impacting a lot of patients,
and it really has the highest impact on our most marginalized populations Erica Kaufman West: Uh, if I can jump in, along those same lines, when we talk about marginalized patients, I always think, I have an HIV clinic and I think of those patients. And initially I thought, "Oh, these folks are, um, they're sort of sheltered because we, we actually do have a fairly, you know, good, HIV safety net," right? You have Ryan White, you have, um, ADAP for medication. So we do a pretty good job of making sure that anybody with HIV has
HIV-related medical care coverage. But that's only for HIV care. So, I had a patient recently with HIV that had an abscessed tooth, and so it was not, not like routine dental work. We needed an oral surgeon to be able to go in there. Couldn't find one. The patient's now looking at a hospitalization. They don't actually have regular medical insurance, so they don't wanna go because now they're worried that, you know, this is gonna become a huge bill. Ends up with osteomyelitis of the mandible and once again, not an uncommon
scenario to all of us when you have these delays in care because people are worried about accessing care, like James said, coming in with more advanced TB disease than was necessary. We start to get these more advanced diseases and thus worse outcomes. Brian Bramson: I could just jump in. You know, I think it's really great to discuss this through a clinical podcast because Sara, I think as you mentioned at the outset, this is not a strange scenario I'm sure for anyone listening to this podcast.
And if I have a concern for us, it's that we, we swim in this sea so much, the water we're not even aware of. But this is not really a normal system, and I really appreciate my colleagues here illustrating a lot of the ways how the system harms those without insurance. I think another thing I just wanna highlight is it doesn't work that well for people who have insurance, and this vi- vignette we just discussed really illustrates some of those things that are integrated even into the
system with people who have insurance. Things like high copays, high deductibles, narrow networks or shifting networks. There was actually a commonwealth study done back in 2016 that found that a third of Americans in the last year have had to either delay or forgo prescribed healthcare because of costs involved. And for comparator, like they looked at how often does that happen
in places like Germany or Great Britain, and the number was about 7%. So, you know, it just doesn't seem to work very well for the patients with, with insurance. There's even statistics out there that the wealthiest 1% of white infants in America have an infant mortality rate greater than that in most of the Scandinavian countries, for instance. So even our most privileged don't get to enjoy the good healthcare outcomes.
So I don't think the system is working well for patients really across the spectrum. also, and I think we can all resonate with this, it doesn't work well for us either professionally. We spend a lot of our time trying to clear completely artificial bureaucratic hurdles that have been put in place, um, trying to get prior authorizations. I think everyone listening to this, I'm sure, has done a peer-to-peer telephone
interview that was essentially pointless. You know, we, um, also spend an excessive amount of time in our documentation compared to other peers in developed countries, and a lot of that is because our documentation is not really driven by clinical communication. It's driven by charge capture and every clinic visit, every consult has to meet multiple different criteria that are often different compared to who the payer
is in order to, to get reimbursement. I came across just a mind-blowing uh, comparison a while back. So Duke University Hospital, which is just up the road from where I practice in Chapel Hill, um, sometimes it hurts me to admit it, but they're a fantastic hospital. Uh, 957 beds the last time I, I, I looked, and that number was from 2018, so it, it might have grown. But for a 957-bed hospital in 2018, Duke was employing 1,600
people in their billing department. Now, Christian Hendrix: No, no Brian Bramson: seems already like a lot. If you look at the hospital at, um, the University of Toronto Hospital, which is about a 1,270-bed hospital, around the same time in 2019, that hospital system employed seven people in their billing department. And a lot of that because they have a very simplified single-payer billing system,
and you can easily just extrapolate all those overhead costs to really every group practice, every private practice in every specialty in the United States. Every hospital spends a lot of time on administrative overhead. So not working r- really for patients. It's not working for us. It's just not working Erica Kaufman West: Yeah, and I, I would like to expound a little bit on the effect of, on us, uh, physicians. It's, it's obviously everyone in healthcare, doctors,
nurses, you know, NPs/PAs. But for us specifically as physicians, as we said, I think multiple times, the case that we presented is not unique, right? We all can think of a case where we had to change what we wanted to do, what was best practice, and, and a lot of times what was actually evidence-based, and change it to fit what the insurer would do or what they would cover. And so we are all… If you, if you think of it, it's not just that we're like, "Oh, I'm just gonna pick this other antibiotic." You
are being asked to make compromises in the care that you're providing. So, like, if you sit with that for a second, you're being asked to compromise the care for this patient, and we are so used to this. From the time we're in medical school, we think that this is just the way medicine works, it is here, but it's not the way that it has to be 'cause it's not the way it is in other countries. It brings to mind that idea of death by a thousand paper cuts, and I, I think that's
what is happening to us as physicians. So, this is moral injury and moral distress through a thousand decisions to instead do plan B or plan C or plan D instead of plan A. So, it's choosing the slightly lesser antibiotic because of cost, or it's having someone go home with OPAT instead of the skilled nursing facility (SNF) when you know they're gonna struggle with ADLs, and you know they're not gonna give that antibiotic every six hours at home because who can do that?
And if you stop to think about it, we do this all the time. All of those paper cuts, all of those conscious decisions to provide lesser care, it's driving us out of medicine, it's blanketing us in depression and suicidality, and it's decreasing our quality of life. There have been a lot of surveys over the years that show that people in healthcare suffer from moral injury at higher rates than other jobs in the US, and often this gets labeled as burnout, right? Doctors are burning out. Nurses are burning out.
That's why we're all leaving medicine. But I actually don't think it's burnout. So, we all know how to work long hours. We all know that we're missing birthday parties and cousins' weddings and holiday events. We signed up for a profession that requires sacrifice and precision, and we knew this, and we have done it. That's not the problem. What we didn't sign up for was that feeling of beating your head against the wall, making dozens of phone calls to try and get an HIV med approved or doing
that pointless peer-to-peer, like Brian said, only to realize that's not the end. This is going to continue for the next patient and the next day because that's the way the system is built. It's designed to maximize profits, and it doesn't care that it's chipping away at our morality. And physicians suffer from this, and patients suffer, but we suffer as physicians James Lewis: Yeah. Uh, Erica, I totally agree with you and Brian. I wanted to jump in and explore that concept of the physicians and patients
suffering, uh, from a specific angle. So I mentioned I work a lot with TB patients and I'm in public health, and I have the luxury of pretty much scheduling as much time as I want with patients. We don't do any billing. We may start doing some billing at some point, since, you know, public health is hurting, uh, as you can imagine at this point in time. Uh, but regardless, it will not be the focus by any means. And, and right now we don't bill at all. And so I routinely spend an hour and sometimes more with, with a TB patient, and it really brought to light this concept, uh, that this whole setup really
creates an adversarial relationship between us and the patients who actually need us and need our time the most. And most of that interaction is not gonna be reimbursable or meet our RVUs past a certain point, certainly. And that puts us, personally, potentially in a, in a adversarial situation with regard to bonuses or reimbursement, and then also potentially puts us in a negative light or footing with the organization we work for. Uh, and then that is definitely gonna lead to the concept you were talking
about, Erica, with this moral injury. Like, that doesn't feel good, you know? Even if you don't totally realize what's happening. I know I didn't really put that together until I started spending a lot of time with individual patients, more than I could have, during training and previous clinical jobs. And, it definitely feels much better for me. I walk out of that room feeling like I did a good job and like I answered all the questions they had and, uh, there wasn't anything else they needed from me in that moment. And then I, I can't speak for them, but it certainly seems hugely appreciated by
the patients as well, and often they get a lot of questions answered that they have been trying to get answered before. And, and, you know, with this patient population, obviously, uh, English is often a second language, if spoken at all. And so, uh, we work closely with interpreters, which, I know from personal experience, when you're in a rush, in a hurry, it's really hard to have an effective interaction with Erica Kaufman West: Mm-hmm. James Lewis: using an interpreter.Um, you really have to, you know, be intentional and set some time aside for it. so so I definitely agree with you both, and I just wanted to highlight that one specific way that it's hurting us.
Brian Bramson: Thanks, James. I just, if I could, I just wanna jump back in 'cause I really think that you hit something on the head there when you talked about the different kind of practice enabled really by a different payment model. I'm certainly of the opinion that while there is no perfect system, and there is nothing I could describe that would take care of every problem that we have, I do think lot of places have better systems, and I do think there are some pretty exciting proposals being discussed now to really improve that payment model.
And one that I'm very much in favor of that maybe people haven't heard the specifics of too much is what goes under the somewhat problematic term of Medicare for All. And I think really a better way to think about it is improved Medicare for All. The best, most fleshed out bill, for this, proposal for this is the one that's before, Congress right now. And just to acquaint people with what, with what's included in that, it's, it's basically a bill to, to provide comprehensive coverage.
And when I say comprehensive, I mean inpatient, outpatient, primary care, specialty care, pharmacy, vision, hearing, long-term care. All bills for all those services would go directly to the government. It wouldn't really technically be what often goes by the name of socialized medicine because doctors, clinicians, hospitals would still be private. It would just be the bills would all go to, to Medicare. This would be funded really through, taxes.
It would be taxpayer-funded. The proposal that's before Congress calls for no premiums, co-pays, d- deductibles whatsoever. It's paid on the back end by our taxes. It's free at the point of care. So the minute you start talking about taxes, people quite understandably, all of us, get a little anxious about what that means. Well, the nonpartisan Congressional Budget Office looked at the bill, and they scored it, and they came to the conclusion that in about 95% American households, the
amount they would have to pay in increased taxes would be smaller than what those households are currently spending on healthcare because of premiums, co-pays, deductibles, et cetera, and in a lot of cases, it would be substantially less. There was a study done by Yale pretty recently of this, uh, the Medicare for All proposal that's gotten a lot of attention, where they were estimating it would save about 100,000 lives per year and about $1 trillion.
So yeah. One other thing I just wanna kind of address clearly, I know whether my physician colleagues will admit it or not, any time they start hearing things like single payer health insurance Everyone's a little bit worried, "Well, what's, what does that mean for me? I'm still paying off my med school loans, et cetera. I've got kids to put through college." Believe me, I get that. I don't really think there's anything here that ought to
scare us on that, on that front. That same Congressional Budget Office analysis, uh, again, said th- they were predicting that overall payments to physicians were gonna increase under Medicare for All. There's been a couple of really good published studies where they looked at models of single payer that had been introduced in different individual states. So they had fleshed out the specifics of how single payer would work in that state, and then they modeled how that would play out for hypothetical
practices under each of those models. In every one, physician's net income actually increased. Some of this is because you're not spending otherwise productive time doing things that nobody likes, like being on the phone with a peer-to-peer or filling out prior authorizations. There's also the decreased overhead costs associated with billing with a more simplified billing model. And then most of these models haven't even included all these other knock-on effects.
For instance, right now the number one line item in malpractice judgments and settlements is the cost of future healthcare. Well, if you have a Medicare for All system, the cost of anyone's future healthcare is zero. So that is gonna automatically make judgments and settlements smaller, which certainly should make our malpractice premiums smaller. So I really don't think this ought to represent a threat to our profession
economically, although I do feel like that's almost an instinctive way physicians have responded to it, which I think just needs some more education So yeah, if any of the people listening to this podcast wanna find out some more about this or get involved in how to advocate for this kind of change, all of us here in this group are part of, um, an interest group within the Infectious Disease Society of America. You can find us on the IDSA website.
We're the single payer interest group. I'm also a member of an organization called Physicians for a National Health Program, which is the largest physicians advocacy group dedicated really exclusively to achieving single-payer healthcare, and we have about 35, 40,000 of us now and growing all the time. You, you're all welcome to join us Christian Hendrix: Thanks, Brian. Yeah, I'm definitely proud to be a part of, these organizations because
it gives me revolutionary hope. And I would say I'm really appreciative for everything you all have shared today. We have so much information, and having a place to go to gives us something that we can do with this information so we can work with an organized strategy to commit to daily actions. You know, this is a system that's been in place. It's not gonna change overnight. We have to have some type of organized communication and commitment so that we can continue our work that we do already. we are all working hard already.
Um, but we do need a realistic, feasible plan that you outlined, Brian, um, so that we can advocate and fight for healthcare for everyone. I would say I'm over $400,000 in debt, but if you tell me that there's a system that we can use and I will enjoy working with patients more, I will feel more productive as a physician, I'm all for it. Because that's the original reason most of us went into the healthcare field and want to be a physician and talk to patients. Um, so that's why I wanna fight for a better healthcare system.
And definitely would love to see some pe- in the IDSA single-payer interest group. If you aren't connected to someone there or don't happen to be a physician, just look out for other things that are going on as well. You can look to a hospital where you might practice. Your hospital might have an advocacy group. You can connect with the community, see what their needs are, uplift their voices so that we can all get healthcare access for the community. A lot of times I talk to people about the actions that they're doing because
they might be complaining, as I am, about the system that's not working. Sometimes people donate. That can be helpful, but I think at this point, we are really seeing that the system's going to need change. And so if our goal is to impact the system, we have to really work together to do a little bit more daily actions to fight for patients, especially those who right now are being negatively impacted by health, specifically like our trans populations, LGBTQ populations, minorities, immigrants, women's health. Um, we want health equity, so we want everyone to have good health outcomes
and no groups to be left out of that. So even though change might not come quickly or easily, it's our duty. When we're dedicated together, we're very powerful. I've been really empowered Brian, Erica, and James and learning from them, so encourage others as well Brian Bramson: I just wanted to add one other comment. I love this podcast, and I love hearing people talk about how best to care for their patients. I have become a better clinician from this.
If this clinical story, this vignette that we shared sounds familiar to people, I think this is one of those times where the practice change that we need to implement to better care for patients like this one is not a clinical change. It's not something we can prescribe or a test we can order. It's really a system that we have to change, and that's gonna take some advocacy and some involvement. So that would be the treatment plan, I think, for the patient
discussed in this vignette Sara Dong : Thank you so much to our guests today, Christian, Erica, James, and Brian. Don't forget to check out the website febrilepodcast.com, where you can find our consult notes, our library of ID infographics, and a link to our merch store. Febrile is produced with support from the IDSA. Please reach out if you have any suggestions for future shows or want to be more involved with Febrile. Thanks for listening. Stay safe, and I'll see you next time
Learn how to master management of Valley Fever with an expert Coccidioidomycosis team from the University of Arizona including Drs. Taghrid Taha, Fariba Donovan, and Thomas Erwes! Episodes | Consult Notes | Subscribe |...
Sara and Marisu Rueda Altez (University of Alabama Birmingham) chat with the Pediatric ID Fellows Cup (PIDFC) 2026 champions “Sweet Home Histoplasma” (team from UAB) and “RBC BugBusters” (team from Rainbox Children’s...
Drs. Manuel Rodriguez and Manuel Castro-Borobio join Febrile from Georgia to chat about a day in the life of an ID physician in private practice and questions and considerations for new fellows consulting on the job...
Drs. Alok Nimgaonkar and Rebecca Kumar provide an update on definitions for VAD infections! Also mentioned in this episode is a call for the new Febrile Editorial Board!! You can find more information at...
Drs. Veronica Santos, Sebastian Shrager, and Misti Ellsworth share a not so typical case of Brodie abscess! Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com Febrile is produced with...